Business
UMG
Sherwood News

Universal Music shares jump after announcing new Spotify deal

It’s Spotify ft. UMG forever.

Universal Music Group (UMG), the world’s leading music company, and Spotify, the world’s most popular audio-streaming service, yesterday announced a new, multiyear agreement for recorded music and music publishing — sending shares in Universal Music up 7% in early European trading on Monday morning.

The agreement will establish a direct license between UMG’s publishing arm and Spotify’s product portfolio to usher in the “next era of streaming innovation”... which sounds good? It will also, per the press release, introduce new paid subscription tiers and offers, bundle music and nonmusic content together, and ensure artists’ streaming royalties.

Bright spot

The deal comes a month after UMG announced an “expanded global relationship” with Amazon Music, and extends a long-standing partnership between two industry behemoths. Over the last decade, streaming has fast become one of UMG’s biggest meal tickets, making up almost 70% of the company’s recorded music revenue in Q3 2024, equivalent to almost $1.5 billion in just three months.

As stated in the joint press release, UMG and Spotify will work to advance greater monetization for artists and songwriters” — though it is notably light on specific details as to how that will be achieved. But one thing we know for sure is that the audience experience will be... deepened.”

Indeed, streaming royalties remain one of the music business’s most controversial issues, and Spotify is often at the center of those conversations. (The platform’s CEO recently faced backlash for price hikes and layoffs amidst record profits.) While the deal stands to benefit UMG’s major artists like Taylor Swift and Kendrick Lamar, unsigned songwriters are likely to be largely left out of this “mutually beneficial relationship” — particularly in light of Spotify’s 1,000-stream monetization threshold, set in 2023.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.